Trevi Therapeutics, Inc. (TRVI)
11.58
-0.35
(-2.93%)
USD |
NASDAQ |
Apr 01, 16:00
11.60
+0.02
(+0.17%)
After-Hours: 20:00
Trevi Therapeutics Market Cap : 1.446B for April 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Puma Biotechnology, Inc. | 363.30M |
| Bristol Myers Squibb Co. | 128.01B |
| Terns Pharmaceuticals, Inc. | 5.973B |
| ACADIA Pharmaceuticals, Inc. | 3.818B |
| Alnylam Pharmaceuticals, Inc. | 43.34B |
Market Cap Related Metrics
| Price to Book Value | 7.890 |
| Price | 11.58 |
| Earnings Yield | -2.85% |